BRCA1 and breast cancer: A more recent review of the literature and meta-analysis by Zhong and colleagues [24] identified 13 studies that examined the effects of BRCA1/2 on breast cancer survival and found that BRCA1 mutation carriers had worse overall survival than non-carriers (HR = 1.50, p = 0.009) whereas progression-free survival was not different.